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Abstract
Background: Percutaneous fine needle aspiration cytology (FNAC) became a popular method for
diagnosis of hepatic masses. Abdominal wall implantation from FNAC is rare.
Case presentation: We report a female patient who presented with a right upper abdominal wall
mass 3 years following a fine needle aspiration cytology (FNAC) and resection of a solitary
hepatocellular carcinoma (HCC) from the liver. The mass proved to be a metastatic HCC; it was
locally resected with safety margins. To date (20 months later) she remains well with no
recurrence.
Conclusion: Implantation of tumor cells after FNAC for HCC is rare, but can happen. The
availability of dynamic imaging of the liver should reduce the need for this technique in the
diagnostic workup of patients suspected of having HCC
Background
Percutaneous fine needle aspiration cytology (FNAC)
became a popular method for diagnosis of hepatic
masses. The reported mortality rate following this proce-
dure ranges between 0.006% and 0.03%. The associated
morbidity is 0.05% – 0.18%, this includes: hemoperito-
neum, hematoma, local infection, bile peritonitis and
anaphylactic shock [1]. In this report we present a rare
case of abdominal wall implantation of hepatocellular
carcinoma 3 years following FNAC and resection of the
primary lesion.
Case presentation
A 61-year-old female, known to suffer from chronic hepa-
titis C (Child Pugh A), presented in Jan 2001 to another
hospital complaining of abdominal pain. CT-Scan of the
abdomen showed a solitary 5 × 5 cm mass in segment VII
of the liver. Fine needle aspiration cytology (FNAC)
showed features consistent with HCC. AFP level at the
time was normal 2.23 ng/ml (normal < 5.6 ng/ml). She
traveled abroad (outside Kuwait), underwent resection of
the tumor and returned back to Kuwait. A brief report
stated that the tumor was resected from segment VII with
about 1.5 cm safety margin with an uneventful postoper-
ative course. Histopathology of the original tumor proved
to be a well differentiated HCC with clear margins and no
vascular invasion.
Upon return to Kuwait, she was under the care of the
hepatologist who treating her chronic hepatitis with Pege-
lated Interferon and Ribaverin for 6 months. Unfortu-
nately she remained HCV positive.
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In Oct. 2004, three years following her original surgery,
she was referred to the Liver Unit, Mubarak Al-Kabeer
Hospital with an abdominal wall mass of one-year dura-
tion. On physical examination an obvious 7 × 5 cm
smooth oval mass was seen in the right upper quadrant at
the lateral border of her previous right subcostal scar.
Clinically the mass seemed to be within the abdominal
wall and the skin over it was free. CT scan of the abdomen
showed a round well defined enhancing soft tissue den-
sity mass measuring 11 × 5 × 5 cm within the anterior
abdominal wall with no intra-abdominal extension or
skin infiltration (Figure 1). The liver was free except from
signs of previous surgery in segment VII. Tumor markers
were: AFP 6.23 ng/ml (normal < 5.6 ng/ml), CEA 1.5 ng/
ml (normal < 6.9 ng/ml) and CA19-9 15.9 (normal < 43
ng/dl). FNAC from this mass, was consistent with meta-
static HCC (Figure 2). En-bloc  resection of the mass
(including the mass, overlying skin, abdominal wall mus-
cles and peritoneum) was performed under general
anesthesia with primary closure. Histopathology of the
removed specimen confirmed implantation of HCC in the
abdominal muscles with free surgical margin and no peri-
toneal penetration (Figure 3). The patient had an unevent-
ful recovery and was discharged home on the 7th
postoperative day.
To date, 20 months since resection of the metastatic mass,
she remains well with normal AFP and liver functions and
no evidence of recurrence in the liver or abdominal wall.
Discussion
Implantation of hepatocellular carcinoma to the abdomi-
nal wall after percutaneous fine needle aspiration cytology
is rare ranging from 1.4% to 3.4% [1]. The reported risk
factors for tract implantation after FNAC include: the size
of the tumor, degree of histological differentiation of
CT-Scan of the abdominal wall, shows the the mass within the abdominal wall muscles in the right hypochondrium with no  intrperitoneal extension Figure 1
CT-Scan of the abdominal wall, shows the the mass within the abdominal wall muscles in the right hypochondrium with no 
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HCC, a thin layer of liver parenchyma along the needle
tract and the number of needle passes [1-3]. It has been
shown that repeated attempts with the needle during
FNAC are associated with higher chance of implantation
to the abdominal wall [1]. However, implantation was
reported even after a single pass [4]. There seems to be a
greater chance of implantation with end-cutting biopsy
needles [5].
Most HCC patients present with large and poorly differen-
tiated tumors; they have a short survival time. Whereas
patients with small, resectable and well differentiated
tumors live longer and hence the probability of detecting
tumor implantation in the abdominal wall after FNAC is
perhaps higher in this group. The patient presented in this
report had a solitary small well differentiated tumor and
is still alive 5 years since her liver tumor was resected with
normal liver function and no recurrence.
The tumor implantation reported in this patient, may be
due to FNAC or perhaps due to spillage from the tumor
during surgery. We do not have the exact details of the sur-
gical procedure as it was done in a different country. How-
ever, the brief operative report presented to us did not
indicate any surgical mishaps.
Malignant cell seeding is a well known complication of
diagnostic and therapeutic procedures in HCC [6]. Den-
ton et al indicated that there are no prospective studies
about this issue; there is only small series and case reports
in the literature [7]. They indicate that there is an underes-
timation of the risk of tumor implantation in HCC and
FNAC (Fine Needle Aspiration Cytology) from the mass shows polygonal cells forming microacini at places Figure 2
FNAC (Fine Needle Aspiration Cytology) from the mass shows polygonal cells forming microacini at places. Features consist-
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stated that many are not diagnosed or even not reported
[7].
The recent consensus meeting of the EASL(European
Association for the study of the liver) and the AASLD
(American association for the surgery of liver disease) in
Barcelona 2005 indicated that a diagnosis of HCC in the
setting of cirrhosis can confidently be made by two
dynamic imaging techniques if both show increased vas-
cularity characteristic of HCC. The panel accepted the con-
cept of "washout" in the portal venous phase of a CT-Scan
as specific for HCC; this is shown as hypo-attenuation in
the late portal phase of a liver lesion which was hypervas-
cular in the hepatic arterial phase [8]. In addition the
panel agreed that an AFP of > 400 ng/ml together with
only one typical imaging technique is specific for HCC
[8]. Therefore, the introduction of dynamic liver studies
by multidetector CT-Scan or MRI would allow clinicians
to diagnose most cases of HCC with confidence without
FNAC. However few atypical cases do exist and these
would definitely require FNAC. The policy adopted in our
Liver Unit is in accordance with the 2005 Barcelona crite-
ria.
Conclusion
Implantation of tumor cells after FNAC for HCC is rare,
but can happen. The availability of dynamic imaging of
the liver should reduce the need for this technique in the
diagnostic workup of patients suspected of having HCC.
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Histopathological examination of the excised mass Figure 3
Histopathological examination of the excised mass. Shows that the tumour is made of thick hepatocyte cell plates with foci of 
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